Secukinumab in the Treatment of Noninfectious Uveitis: Results of Three Randomized, Controlled Clinical Trials

Dick A. D., Tugal-Tutkun I., Foster S., ZIERHUT M., LIEW S. H. M., BEZLYAK V., ...More

OPHTHALMOLOGY, vol.120, no.4, pp.777-787, 2013 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 120 Issue: 4
  • Publication Date: 2013
  • Doi Number: 10.1016/j.ophtha.2012.09.040
  • Journal Name: OPHTHALMOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.777-787
  • Istanbul University Affiliated: Yes

Abstract

Purpose: To determine the efficacy and safety of different doses of secukinumab, a fully human monoclonal antibody for targeted interleukin-17A blockade, in patients with noninfectious uveitis.